Removes 92% of online fraud for global med'l firm

RNS Number : 4815L
Brandshield Systems PLC
13 September 2021
 

NEWS RELEASE

 

BrandShield confirms removal of 92% of fraudulent online product distribution for global medical firm

 

BrandShield's solution used AI to map threats and grey market goods - reaching 92% infringement detection and takedown rate in just its first month of bolstering cybersecurity efforts

 

13/09/2021: BrandShield (LSE: BRSD), a cybersecurity company specialising in monitoring, detecting, and removing online threats provides a holistic brand protection solution to high-end medical and home-based aesthetics  solutions provider Pollogen , resulting in removal of 92% of IP-infringing listings and counterfeit products from the internet, within the first month.

 

BrandShield was enlisted by Pollogen to combat the surge in online counterfeiting, grey market products and fraudulent use of trademark rights across the web. Recognising the substantial risk posed to its brand, Pollogen, owned by the global medical device leader Lumenis, sought out BrandShield's leading cybersecurity protection capabilities in response to detecting a surging number of unregulated products.

 

Within the first month, BrandShield's cybersecurity platform achieved an 92% infringement detection and takedown rate, taking back control of Pollogen's digital presence and protecting their global customer base. Dealing with unauthorised sellers caused both Pollogen and its stakeholders to invest enormous effort and resources. By deploying BrandShield, these concerns were quickly resolved.

 

BrandShield utilises AI to form an effective and proactive approach to threat mapping and the takedown of fraudulent activity. The Company was able to use its wealth of experience supporting similarly targeted brands to take action, swiftly arresting the growing presence of counterfeit and grey goods, as well as online trademark infringements.

 

Consequently, the cybersecurity firm has removed more than 1,420 shady listings for the medical device company to date, resulting in the vast majority of threats being taken down.

 

Michele Michaeli, VP of Marketing at Pollogen, said: "Pollogen is always in a constant battle against counterfeiters and unauthorised sales and this fight is an essential element in supporting our global distribution network. Since working with BrandShield, we have begun a process of mapping out online threats, prioritising them, identifying major counterfeit networks, and then removing them from the internet. We have had a phenomenal takedown success rate in both the Chinese and Western marketplaces. Now we are always in control of our digital environment, meaning we can continue to focus on delivering excellent products to our loyal customers and supporting our partners and distributors across the world."

Yoav Keren, co-founder and CEO of BrandShield, added: "Every day, IP infringers are constantly trying to become smarter in their efforts to imitate world-renowned brands and, as a respected international company with a distribution network across 60 countries, Pollogen needed to act. Michele came to us to develop a comprehensive strategy to protect both the firm's brand integrity and customer loyalty. Working with Pollogen and its distribution network, we created a flexible AI-powered solution to reduce the number of fraudulent sites, strengthen authorised distribution channels, and solidify trust in Pollogen's brand image. A unified effort between people and technology has made this solution the best fit for Pollogen and the company can now enjoy a sense of control over its business once more."

 

For more information, please visit: https://www.brandshield.com/

 

 

- ENDS -

 

 

About BrandShield

BrandShield is a leading cybersecurity company founded in Israel by cybersecurity experts that protect the world's largest brands and consumers from phishing attacks, online fraud, and other online threats posed by dangerous cybercriminals. Through its AI/ML platform, BrandShield identifies, tracks, and eliminates online threats for global brands and organizations, including Bristol Myers Squibb, Levi's, NewBalance, Swisscom, and the Pharmaceutical Security Institute. BrandShield is listed on the London Stock Exchange AIM under the ticker symbol BRSD. To learn more about BrandShield, please visit the company website at www.BrandShield.com .

 

About Pollogen

Pollogen Ltd., a company of Lumenis, is a global leader in the medical and home-based aesthetics markets, providing innovative, safe, and effective solutions that enhance and expand the practice of medical aesthetics professionals, as well as private aesthetic customers. The company offers products to support a range of skin treatments, based on its proprietary technologies, namely Tripollar RF, Voluderm, Trifractional, Oxygeneo and DMA. Pollogen provides solutions for professionals and consumers in more than 60 countries, addressing the specific needs of its professional clients and private customers in the dynamic aesthetic industry. For more information visit: www.pollogen.com

 

For more information, please contact:

 

BrandShield Systems plc

Yoav Keren, CEO

 

 

+44 (0)20 3143 8300

Spark Advisory Partners Limited (Nominated Adviser)

Neil Baldwin / Andrew Emmott / James Keeshan

 

+44 (0)20 3368 3554

Shore Capital (J oint Broker)

Toby Gibbs / James Thomas (Corporate Advisory)

Henry Willcocks (Corporate Broking)

 

 

+44 (0)20 7408 4090

Tennyson Securities (Joint Broker)

Peter Krens

 

+44 (0)20 3368 3554

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Antonia Pollock

brandshield@vigoconsulting.com

+44 (0)20 7390 0237

 

About Reach announcements

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRALTMLTMTTBMIB
UK 100

Latest directors dealings